tirzepatide for pcos vs metformin Your Body Isn't Broken: How GLP-1 Medications Are Changing The Game Pharmacological Options for PCOS Obesity – Yes! Tirzepatide can help patients

Clinical data from the SUSTAIN diabetes program and STEP obesity program showed low rates of ADA development (3-7% of patients across trials), with most ADAs being non-neutralizing and not associated with clinically meaningful reductions in efficacy

The two most well-known GLP-1 agonists are semaglutide (Ozempic and Wegovy) and tirzepatide (Zepbound and Mounjaro)

Semaglutide isnt associated with mood changes in clinical trials, but the combination of a new medication, changing eating patterns, and managing a chronic condition can feel a lot at once

FIGURE 1 3.2 Study characteristics Table 2 details the included studies

PCL-C for DSM-IV